Catalog Products » Antibodies » Primary Antibodies » Cytokine and Growth Factor Antibodies » Vascular Endothelial Growth Inhibitor (VEGI), human
Email to GenScript
 
Search by Catalog Number :
Search by Name :
Search by Sequence : (One letter code)
Search by Category :



Vascular Endothelial Growth Inhibitor (VEGI), human



Cat. No.
Name
Size   
Price
Selected
Z02198-50
50 μg
$725

Protein Vascular Endothelial Growth Inhibitor (VEGI), human
Synonyms
VEGI (Human); VEGI-192; rHuVEGI;
Documents
Purity
The purity of GenScript Recombinant Human VEGI-192 is greater than 95.0%, as determined by the following methods:
(a) RP-HPLC analysis
(b) Reducing and non-reducing SDS-PAGE silver-stained gel analysis
Endotoxin Level
The endotoxin level of GenScript Recombinant Human VEGI-192 is below 0.1 ng/µg (1 IEU/µg) of rHuVEGI.
Specificity
The ED50, as determined by the dose-dependant inhibition of the proliferation of HUVEC (Human Umbilical Vein Endothelial Cells), is less than 5 μg/ml.
Source
E. coli
Amino Acid Sequence
The sequence of the
first five N-terminal amino
acids has been found
to be Met-Gln-Leu-Thr-Lys.
Molecular Weight
21,858 Da
Formulation
GenScript Recombinant Human VEGI-192 is lyophilized after extensive dialysis against 0.5 M NaCl, 50 mM Tris-HCl buffer, pH 7.5.
Reconstitution
It is recommended that the lyophilized VEGI-192 be reconstituted in sterile 18 MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions.
Storage
Although lyophilized VEGI-192 can remain stable at room temperature for up to three weeks, it is best stored desiccated below -18°C. After reconstitution, VEGI-192 may be stored at 4°C for up to seven days and below -18°C for longer periods. For long-term storage, it is recommended that a carrier protein (0.1% HSA or BSA) be added. Please avoid freeze-thaw cycles.
1
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 .
2
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins.
3
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems.
4
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells.
5
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level.